Innovative Eyewear Inc. (LUCY)vsWest Pharmaceutical Services Inc (WST)
LUCY
Innovative Eyewear Inc.
$0.84
-2.03%
HEALTHCARE · Cap: $7.87M
WST
West Pharmaceutical Services Inc
$374.65
+0.76%
HEALTHCARE · Cap: $25.69B
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 97403% more annual revenue ($3.33B vs $3.41M). WST leads profitability with a 17.0% profit margin vs -225.3%. WST earns a higher WallStSmart Score of 59/100 (C).
LUCY
Avoid33
out of 100
Grade: F
WST
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+23.1%
Fair Value
$1.43
Current Price
$0.84
$0.59 discount
Margin of Safety
-44.6%
Fair Value
$170.28
Current Price
$374.65
$204.37 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 74.5% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Strong operational efficiency at 22.5%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -102.4% — below average capital efficiency
Negative free cash flow — burning cash
Trading at 8.8x book value
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : LUCY
The strongest argument for LUCY centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 74.5% demonstrates continued momentum.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 22.5%. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : LUCY
The primary concerns for LUCY are EPS Growth, Market Cap, Return on Equity.
Bear Case : WST
The primary concerns for WST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 46.8x leaves little room for execution misses.
Key Dynamics to Monitor
LUCY profiles as a hypergrowth stock while WST is a mature play — different risk/reward profiles.
LUCY carries more volatility with a beta of 2.74 — expect wider price swings.
LUCY is growing revenue faster at 74.5% — sustainability is the question.
WST generates stronger free cash flow (81M), providing more financial flexibility.
Bottom Line
WST scores higher overall (59/100 vs 33/100), backed by strong 17.0% margins and 13.8% revenue growth. LUCY offers better value entry with a 23.1% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Innovative Eyewear Inc.
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Innovative Eyewear Inc. (LUCY) stands at the forefront of the smart eyewear sector, merging advanced technology with appealing aesthetics to meet the needs of modern, tech-savvy consumers. Its flagship product line, Lucyd, is designed to provide integrated audio features and seamless connectivity, offering a blend of convenience and style. Firmly focused on enhancing user experience and driving innovation, LUCY is well-positioned to leverage the growing demand for multifunctional eyewear, creating significant growth opportunities in a rapidly evolving market. As the trend towards smart, connected devices accelerates, LUCY’s strategic initiatives to promote its product offerings place it in a strong position for long-term competitiveness and success.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?